Physician profile
Patrick Drummond
NPI 1295936821
$1,503.55
in general payments reported to CMS, 2019-2025
15 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.82 · 2023: $54.93 · 2024: $904 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $593.46 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Abbott Laboratories | $157.38 | 2024-2025 | Freestyle Libre 3 |
| Abbvie INC. | $125.00 | 2024 | |
| Neurocrine Biosciences, INC. | $107.93 | 2023-2025 | Ingrezza |
| Bayer Healthcare Pharmaceuticals INC. | $102.44 | 2023-2025 | |
| Exact Sciences Corporation | $89.49 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $82.26 | 2025 | Repatha |
| Glaxosmithkline, LLC. | $57.18 | 2025 | Trelegy Ellipta, Arexvy |
| Dexcom, INC. | $39.12 | 2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $38.98 | 2024-2025 | Rybelsus, Ozempic |
| Reprise Biomedical, INC. | $34.74 | 2025 | Miro3d |
| Smith+Nephew, INC. | $30.93 | 2025 | Collagenase Santyl |
| Collegium Pharmaceutical, INC. | $19.82 | 2021 | |
| Lilly USA, LLC | $16.74 | 2024 | Zepbound, Mounjaro |
| Advanced Oxygen Therapy INC. | $8.08 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Drummond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.